122 related articles for article (PubMed ID: 2129154)
1. Thiol-containing cross-linking agent with enhanced steric hindrance.
Greenfield L; Bloch W; Moreland M
Bioconjug Chem; 1990; 1(6):400-10. PubMed ID: 2129154
[TBL] [Abstract][Full Text] [Related]
2. Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins.
Cumber AJ; Westwood JH; Henry RV; Parnell GD; Coles BF; Wawrzynczak EJ
Bioconjug Chem; 1992; 3(5):397-401. PubMed ID: 1329989
[TBL] [Abstract][Full Text] [Related]
3. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.
Woo BH; Lee JT; Park MO; Lee KR; Han JW; Park ES; Yoo SD; Lee KC
Arch Pharm Res; 1999 Oct; 22(5):459-63. PubMed ID: 10549572
[TBL] [Abstract][Full Text] [Related]
4. Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
Dosio F; Arpicco S; Adobati E; Canevari S; Brusa P; De Santis R; Parente D; Pignanelli P; Negri DR; Colnaghi MI; Cattel L
Bioconjug Chem; 1998; 9(3):372-81. PubMed ID: 9576812
[TBL] [Abstract][Full Text] [Related]
5. New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability.
Arpicco S; Dosio F; Brusa P; Crosasso P; Cattel L
Bioconjug Chem; 1997; 8(3):327-37. PubMed ID: 9177838
[TBL] [Abstract][Full Text] [Related]
6. Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolane.
Carroll SF; Bernhard SL; Goff DA; Bauer RJ; Leach W; Kung AH
Bioconjug Chem; 1994; 5(3):248-56. PubMed ID: 7918744
[TBL] [Abstract][Full Text] [Related]
7. Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkages.
Thorpe PE; Wallace PM; Knowles PP; Relf MG; Brown AN; Watson GJ; Blakey DC; Newell DR
Cancer Res; 1988 Nov; 48(22):6396-403. PubMed ID: 3263186
[TBL] [Abstract][Full Text] [Related]
8. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.
Thorpe PE; Wallace PM; Knowles PP; Relf MG; Brown AN; Watson GJ; Knyba RE; Wawrzynczak EJ; Blakey DC
Cancer Res; 1987 Nov; 47(22):5924-31. PubMed ID: 3499221
[TBL] [Abstract][Full Text] [Related]
9. Enhanced stability of an immunotoxin made with abrin A chain and a hindered disulphide cross-linker.
Cumber A; Wawrzynczak E
Biochem Soc Trans; 1992 Nov; 20(4):312S. PubMed ID: 1486982
[No Abstract] [Full Text] [Related]
10. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
Ramakrishnan S; Bjorn MJ; Houston LL
Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
[TBL] [Abstract][Full Text] [Related]
11. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates.
Candiani C; Franceschi A; Chignola R; Pasti M; Anselmi C; Benoni G; Tridente G; Colombatti M
Cancer Res; 1992 Feb; 52(3):623-30. PubMed ID: 1732050
[TBL] [Abstract][Full Text] [Related]
12. Substituted 2-iminothiolanes: reagents for the preparation of disulfide cross-linked conjugates with increased stability.
Goff DA; Carroll SF
Bioconjug Chem; 1990; 1(6):381-6. PubMed ID: 2099186
[TBL] [Abstract][Full Text] [Related]
13. The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond.
Ghetie V; Thorpe P; Ghetie MA; Knowles P; Uhr JW; Vitetta ES
J Immunol Methods; 1991 Sep; 142(2):223-30. PubMed ID: 1717600
[TBL] [Abstract][Full Text] [Related]
14. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
Rosenblum MG; Marks JW; Cheung LH
Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of aryl thioethers through the N-chlorosuccinimide-promoted cross-coupling reaction of thiols with Grignard reagents.
Cheng JH; Ramesh C; Kao HL; Wang YJ; Chan CC; Lee CF
J Org Chem; 2012 Nov; 77(22):10369-74. PubMed ID: 23067042
[TBL] [Abstract][Full Text] [Related]
16. Negative ion fragmentations of disulfide-containing cross-linking reagents are competitive with aspartic acid side-chain-induced cleavages.
Calabrese AN; Wang T; Bowie JH; Pukala TL
Rapid Commun Mass Spectrom; 2013 Jan; 27(1):238-48. PubMed ID: 23239338
[TBL] [Abstract][Full Text] [Related]
17. Photoactivation of toxin conjugates.
Goldmacher VS; Senter PD; Lambert JM; Blättler WA
Bioconjug Chem; 1992; 3(2):104-7. PubMed ID: 1515463
[TBL] [Abstract][Full Text] [Related]
18. Succinylated polylysine as a possible link between an antibody molecule and deferoxamine.
Slinkin MA; Klibanov AL; Khaw BA; Torchilin VP
Bioconjug Chem; 1990; 1(4):291-5. PubMed ID: 2096922
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Jan; 44(1):201-8. PubMed ID: 6140077
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effects of ricin without an interchain disulfide bond: genetic modification and chemical crosslinking studies.
Mohanraj D; Ramakrishnan S
Biochim Biophys Acta; 1995 Apr; 1243(3):399-406. PubMed ID: 7727515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
